首页> 外文期刊>Therapeutic advances in respiratory disease. >Methylprednisolone infusion for life-threatening H1N1-virus infection
【24h】

Methylprednisolone infusion for life-threatening H1N1-virus infection

机译:甲基泼尼松龙输注治疗威胁生命的H1N1病毒感染

获取原文
           

摘要

Background: During winter 2009 we treated with prolonged corticosteroid infusion eight consecutive patients affected by H1N1-virus infection and severe pneumonia. The most severe patient was a previously healthy 30-year-old man admitted to hospital because of bilateral pneumonia and severe acute respiratory failure.Method: H1N1-virus infection was detected by broncho-alveolar lavage performed on day 1. After some days following admission the patient was still in a life-threatening state, not responding to oseltamivir, protective mechanical ventilation and veno-arterial extracorporeal membrane oxygenation (ECMO).Results: The addition of methylprednisolone infusion at a stress dose (1 mg/kg/24 h) as rescue therapy significantly and rapidly improved the clinical condition. Weaning from ECMO and invasive mechanical ventilation was possible within a relatively few days.Conclusion: According to the literature reports more than 34% of H1N1-virus severe infections were treated with corticosteroids. This report and our experience may suggest a possible life-saving use of corticosteroids at a stress dose in severely ill patients with an H1N1-virus infection that is not responding to the most advanced treatments.
机译:背景:2009年冬季,我们连续接受了8例H1N1病毒感染和严重肺炎影响的皮质类固醇激素输注治疗。最严重的患者是因双侧肺炎和严重的急性呼吸衰竭而入院的一名先前健康的30岁男性。方法:在第1天进行支气管肺泡灌洗检测到H1N1病毒感染。患者仍处于危及生命的状态,对奥司他韦,保护性机械通气和静脉-动脉体外膜氧合(ECMO)无反应。结果:以压力剂量(1 mg / kg / 24 h)添加甲基泼尼松龙输注作为抢救疗法,显着并迅速改善了临床状况。结论:根据文献报道,超过34%的H1N1病毒严重感染接受了皮质类固醇激素治疗。这份报告和我们的经验可能表明,在对最先进的治疗没有反应的H1N1病毒感染的重症患者中,以一定剂量服用皮质类固醇可能可以挽救生命。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号